CEL-SCI Corporation (CVM)
USD 0.24
(-22.03%)
USD 0.24
(-22.03%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 11.6 Million USD | -14.51% |
| 2022 | 13.57 Million USD | -11.14% |
| 2021 | 15.27 Million USD | 18.7% |
| 2020 | 12.86 Million USD | -4.74% |
| 2019 | 13.5 Million USD | 0.96% |
| 2018 | 13.37 Million USD | 1.27% |
| 2017 | 13.21 Million USD | 101444.27% |
| 2016 | 13.01 Thousand USD | 1.78% |
| 2015 | 12.78 Thousand USD | 41.59% |
| 2014 | 9028.00 USD | -56.86% |
| 2013 | 20.92 Thousand USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 3000.00 USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 32.88 Thousand USD | -94.86% |
| 2002 | 639.28 Thousand USD | 1947.82% |
| 2001 | 31.21 Thousand USD | 25.77% |
| 2000 | 24.82 Thousand USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | -100.0% |
| 1995 | 600 Thousand USD | 0.0% |
| 1994 | 600 Thousand USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | 0.0% |
| 1990 | - USD | 0.0% |
| 1989 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 9.96 Million USD | 0.0% |
| 2024 Q2 | 10.53 Million USD | 0.0% |
| 2024 Q1 | 11.06 Million USD | 0.0% |
| 2023 Q3 | 12.11 Million USD | -3.95% |
| 2023 Q1 | 13.09 Million USD | -3.48% |
| 2023 Q2 | 12.61 Million USD | -3.73% |
| 2023 FY | 11.6 Million USD | -14.51% |
| 2023 Q4 | 11.6 Million USD | -4.21% |
| 2022 Q1 | 14.86 Million USD | -2.7% |
| 2022 Q4 | 13.57 Million USD | -3.2% |
| 2022 Q3 | 14.02 Million USD | -2.86% |
| 2022 Q2 | 14.43 Million USD | -2.88% |
| 2022 FY | 13.57 Million USD | -11.14% |
| 2021 Q4 | 15.27 Million USD | 4.86% |
| 2021 Q3 | 14.56 Million USD | 11.31% |
| 2021 Q2 | 13.08 Million USD | 4.11% |
| 2021 Q1 | 12.56 Million USD | -2.32% |
| 2021 FY | 15.27 Million USD | 18.7% |
| 2020 Q3 | 13.14 Million USD | 0.8% |
| 2020 FY | 12.86 Million USD | -4.74% |
| 2020 Q1 | 13.28 Million USD | -1.63% |
| 2020 Q2 | 13.04 Million USD | -1.83% |
| 2020 Q4 | 12.86 Million USD | -2.15% |
| 2019 Q2 | 13.44 Million USD | 0.23% |
| 2019 FY | 13.5 Million USD | 0.96% |
| 2019 Q4 | 13.5 Million USD | 0.24% |
| 2019 Q3 | 13.47 Million USD | 0.23% |
| 2019 Q1 | 13.41 Million USD | 0.26% |
| 2018 Q1 | 13.25 Million USD | 0.33% |
| 2018 FY | 13.37 Million USD | 1.27% |
| 2018 Q4 | 13.37 Million USD | 0.32% |
| 2018 Q3 | 13.33 Million USD | 0.31% |
| 2018 Q2 | 13.29 Million USD | 0.3% |
| 2017 Q2 | 13.11 Thousand USD | 0.37% |
| 2017 FY | 13.21 Million USD | 101444.27% |
| 2017 Q4 | 13.21 Million USD | 100294.57% |
| 2017 Q3 | 13.16 Thousand USD | 0.38% |
| 2017 Q1 | 13.06 Thousand USD | 0.39% |
| 2016 FY | 13.01 Thousand USD | 1.78% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q4 | 13.01 Thousand USD | 0.0% |
| 2015 Q2 | 4583.00 USD | -32.83% |
| 2015 Q4 | - USD | -100.0% |
| 2015 Q3 | 2309.00 USD | -49.62% |
| 2015 Q1 | 6823.00 USD | -24.42% |
| 2015 FY | 12.78 Thousand USD | 41.59% |
| 2014 Q1 | 24.44 Thousand USD | 16.82% |
| 2014 Q2 | 13.34 Thousand USD | -45.43% |
| 2014 FY | 9028.00 USD | -56.86% |
| 2014 Q4 | 9028.00 USD | -19.4% |
| 2014 Q3 | 11.2 Thousand USD | -16.03% |
| 2013 Q1 | 27.2 Thousand USD | 0.0% |
| 2013 Q4 | 20.92 Thousand USD | -9.42% |
| 2013 Q3 | 23.1 Thousand USD | -8.31% |
| 2013 Q2 | 25.19 Thousand USD | -7.39% |
| 2013 FY | 20.92 Thousand USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q3 | 1.06 Million USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | -100.0% |
| 2009 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 FY | - USD | -100.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | -100.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | 3000.00 USD | 0.0% |
| 2005 FY | 3000.00 USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | -100.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | -100.0% |
| 2003 Q2 | 281.49 Thousand USD | -73.88% |
| 2003 Q1 | 1.07 Million USD | 68.56% |
| 2003 FY | 32.88 Thousand USD | -94.86% |
| 2003 Q4 | 32.88 Thousand USD | -68.89% |
| 2003 Q3 | 105.7 Thousand USD | -62.45% |
| 2002 Q3 | 54.99 Thousand USD | -95.08% |
| 2002 Q1 | 1 Million USD | 3103.28% |
| 2002 Q4 | 639.28 Thousand USD | 1062.49% |
| 2002 Q2 | 1.11 Million USD | 11.78% |
| 2002 FY | 639.28 Thousand USD | 1947.82% |
| 2001 Q1 | 24.82 Thousand USD | 0.0% |
| 2001 Q4 | 31.21 Thousand USD | 0.0% |
| 2001 Q3 | - USD | -100.0% |
| 2001 FY | 31.21 Thousand USD | 25.77% |
| 2001 Q2 | 24.82 Thousand USD | 0.0% |
| 2000 Q4 | 24.82 Thousand USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 FY | 24.82 Thousand USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1996 FY | - USD | -100.0% |
| 1996 Q2 | 400 Thousand USD | -20.0% |
| 1996 Q3 | 800 Thousand USD | 100.0% |
| 1996 Q4 | - USD | -100.0% |
| 1996 Q1 | 500 Thousand USD | -16.67% |
| 1995 FY | 600 Thousand USD | 0.0% |
| 1995 Q3 | 700 Thousand USD | -12.5% |
| 1995 Q1 | 600 Thousand USD | 0.0% |
| 1995 Q2 | 800 Thousand USD | 33.33% |
| 1995 Q4 | 600 Thousand USD | -14.29% |
| 1994 FY | 600 Thousand USD | 0.0% |
| 1994 Q4 | 600 Thousand USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AIM ImmunoTech Inc. | 495 Thousand USD | -2243.942% |
| Ampio Pharmaceuticals, Inc. | - USD | -Infinity% |
| Armata Pharmaceuticals, Inc. | 82.3 Million USD | 85.903% |
| Actinium Pharmaceuticals, Inc. | 1.57 Million USD | -638.073% |
| Azitra, Inc. | 563.69 Thousand USD | -1958.307% |
| Can-Fite BioPharma Ltd. | 13 Thousand USD | -89150.108% |
| Chromocell Therapeutics Corporation | - USD | -Infinity% |
| Calidi Biotherapeutics, Inc. | 2.06 Million USD | -463.229% |
| iBio, Inc. | 3.5 Million USD | -230.839% |
| Lineage Cell Therapeutics, Inc. | 2.07 Million USD | -460.508% |
| MAIA Biotechnology, Inc. | - USD | -Infinity% |
| Matinas BioPharma Holdings, Inc. | 2.89 Million USD | -300.778% |
| Navidea Biopharmaceuticals, Inc. | 1.87 Million USD | -519.887% |
| NovaBay Pharmaceuticals, Inc. | 1.1 Million USD | -947.158% |
| NanoViricides, Inc. | - USD | -Infinity% |
| Oragenics, Inc. | - USD | -Infinity% |
| BiomX Inc. | 5.4 Million USD | -114.782% |
| BiomX Inc. | 5.4 Million USD | -114.782% |
| Protalix BioTherapeutics, Inc. | 4.62 Million USD | -151.082% |
| Palatin Technologies, Inc. | 163.78 Thousand USD | -6984.12% |
| Scorpius Holdings, Inc. | 12.61 Million USD | 8.013% |
| Theriva Biologics, Inc. | 162 Thousand USD | -7062.046% |